Pfizer Inc (PFE)

0 · Reply

morgangj May. 20 at 2:16 AM

0 · Reply

EmbraceVolatility May. 20 at 1:51 AM

$PFE overnight volume 1500 shs 😆

0 · Reply

Skyhigh_69 May. 20 at 1:34 AM

$PFE This turd looks nice here

1 · Reply

Sjs360 May. 20 at 12:46 AM

$TTD $PFE $NKE So good at losing money

1 · Reply

_Crim_Jamer_ May. 20 at 12:26 AM

$PFE tiny gains toady! Let's go!

1 · Reply

Mike22332233 May. 19 at 11:56 PM

$SLS UPDATED ... Timeline/Price Prediction: ... SLS will jump to $18-$22 at 80th event ... and then RUN UP TO $55-$60 on GROUNDBREAKING readout results a month later !!! ... from there, it will drift up to the $75-$80 area over the next month ... and soon after, the opening BO Offer will be place at about $140-$160 ... After, a 3 way Bidding War --between $MRK, $PFE, and $ABBV -- the FINAL BO PRICE will be reached at $222 in Q4 of 2026 !!! ... If you agree, LIKE & FOLLOW me 👉 @Mike22332233 as I uncover and post my Special Situation Stocks that have potential for HUGE & QUICK profits ahead ... which I always plow back into more $SLS !!!

1 · Reply

55X_ROI_Q1_2026 May. 19 at 11:37 PM

$SLS $SLS it is inevitable - the 80th Event PR is coming, Phase 3 Registrational Results and FDA Green light worth $40B to big Pharma - are Coming. ANY - DAY - NOW GPS P3 Results - truly worth $40B + the Instant the REGAL Results are announced - GPS MOS 30-36 months, BAT 8-10 --- T1 Trading Halt - Gap Up into the $10B MCap Range / $50 Per Share - AND CLIMBING And to Bottom LINE 009 - its worth $27 Per Share Right Now / TAMBICICLIB Will Be FDA Approved - the Market Has yet to appreciate its value. -- Gleevic - Imatinib, Imbrutinib -- Imbruvica, -- Upadactinib -- Rinvoq Upadactinib <- say that 3 x fast $PFE Pfizers' Ibrance - Palbociclib CDKinase Inhibitor Novartis' Kisqali -Ribociclib CDKinase Inhibitor $LLY Eli Lilly's Verzenio - Abemaciclib CDKinase Inhibitor $SLS Tambiciclib CDKInase Inhibitor reddit.com/r/sellasLifescience ... for anyone interested in DD/ i been here -invested a long time/ if you have an interest in $

1 · Reply

Ro_Patel May. 19 at 10:53 PM

Today's option volume of 63.2M contracts was -13.00% below recent avg levels, w/ calls leading puts 9 to 7. Index (6.8M contracts on 1.62M trades) & ETF products (27.6M contracts on 3.32 trades) on relatively heavy volume, while single stock flow was moderate (28.8M contracts on 4.93M trades) Today's most active sectors included Utilities, Health Care, & Telecommunications, while Financials & Technology were relatively light. Among the 500 most liquid single stocks, 30day IV was higher for 204 & lower for 241. Unusual total option volume was observed in $POET $NOW $PFE $JD & $TGT

1 · Reply

simonds May. 19 at 9:59 PM

$PFE Buckle up, we soar from here!

2 · Reply

PFE, NVO, LLY: Pharma Stocks Drop as TrumpRx Set for ‘Dramatic Expansion’

AZN LLY NVO SNY

May 18, 2026, 8:00 AM EDT - 1 day ago

Astellas to Present Data on Long-Term Outcomes and Clinical Use of Its Portfolio Across Disease Stages at ASCO 2026

May 14, 2026, 2:22 PM EDT - 5 days ago

Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch

DGX MO CL

2026-05-14T17:29:38.000Z - 5 days ago

Pfizer price target raised to $26 from $25 at Wolfe Research

2026-05-13T19:23:39.000Z - 6 days ago

Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:22:15.000Z - 6 days ago

Arvinas price target raised to $16 from $14 at BofA

2026-05-13T11:10:14.000Z - 6 days ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

May 13, 2026, 6:45 AM EDT - 6 days ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

2026-05-13T07:12:25.000Z - 6 days ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

2026-05-12T17:45:03.000Z - 7 days ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

2026-05-12T16:35:26.000Z - 7 days ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

2026-05-12T13:02:04.000Z - 7 days ago

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

May 12, 2026, 8:00 AM EDT - 7 days ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 7:00 AM EDT - 7 days ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

2026-05-08T22:49:53.000Z - 11 days ago

Mixed options sentiment in Pfizer with shares down 1.52%

2026-05-07T01:58:20.000Z - 13 days ago

Mixed options sentiment in Pfizer with shares up 0.28%

May 5, 2026, 4:09 PM EDT - 14 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:02 PM EDT - 14 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 11:30 AM EDT - 14 days ago

3 Dividend Stocks for May 2026

SYY WSO

May 5, 2026, 10:00 AM EDT - 14 days ago

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 14 days ago

Pfizer Earnings release: Q1 2026

May 5, 2026, 10:00 AM EDT - 14 days ago

Pfizer Quarterly report: Q1 2026

May 5, 2026, 10:00 AM EDT - 14 days ago

Pfizer Slides: Q1 2026

May 5, 2026, 8:35 AM EDT - 14 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 7:23 AM EDT - 14 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:06 AM EDT - 14 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:05 AM EDT - 14 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

May 5, 2026, 6:55 AM EDT - 14 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:51 AM EDT - 14 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:45 AM EDT - 14 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 1, 2026, 12:37 PM EDT - 18 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Apr 29, 2026, 7:42 AM EDT - 20 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial

$Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma$

Apr 29, 2026, 6:45 AM EDT - 20 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 28, 2026, 10:41 AM EDT - 21 days ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:17 AM EDT - 21 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 24, 2026, 8:36 AM EDT - 25 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Apr 23, 2026, 9:00 AM EDT - 26 days ago

Pfizer Transcript: AGM 2026

Apr 22, 2026, 4:45 PM EDT - 27 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 5:18 AM EDT - 27 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 21, 2026, 11:51 AM EDT - 4 weeks ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 20, 2026, 3:05 PM EDT - 4 weeks ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 6:45 AM EDT - 4 weeks ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 16, 2026, 1:01 PM EDT - 4 weeks ago

The Big 3: PFE, V, SYF

SYF V

Apr 10, 2026, 11:00 PM EDT - 5 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 9, 2026, 10:00 AM EDT - 5 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 2, 2026, 11:14 AM EDT - 6 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Apr 1, 2026, 11:39 AM EDT - 6 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Apr 1, 2026, 10:13 AM EDT - 6 weeks ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Mar 30, 2026, 10:44 AM EDT - 7 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Mar 24, 2026, 10:00 AM EDT - 2 months ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 23, 2026, 12:46 PM EDT - 2 months ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 9:36 AM EDT - 2 months ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 7:07 AM EDT - 2 months ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:02 AM EDT - 2 months ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 6:47 AM EDT - 2 months ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:45 AM EDT - 2 months ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 22, 2026, 9:45 AM EDT - 2 months ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Mar 20, 2026, 4:30 PM EDT - 2 months ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 19, 2026, 6:45 AM EDT - 2 months ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 18, 2026, 2:23 PM EDT - 2 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Mar 17, 2026, 7:49 AM EDT - 2 months ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Pfizer Proxy statement: Proxy Filing

Mar 12, 2026, 8:00 AM EDT - 2 months ago

Pfizer Proxy statement: Proxy Filing

Mar 9, 2026, 7:27 AM EDT - 2 months ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 6:45 AM EDT - 2 months ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management

Mar 5, 2026, 4:48 PM EST - 2 months ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Skyhigh_69 May. 20 at 4:57 AM

0 · Reply

morgangj May. 20 at 2:16 AM

0 · Reply

EmbraceVolatility May. 20 at 1:51 AM

$PFE overnight volume 1500 shs 😆

0 · Reply

Skyhigh_69 May. 20 at 1:34 AM

$PFE This turd looks nice here

1 · Reply

Sjs360 May. 20 at 12:46 AM

$TTD $PFE $NKE So good at losing money

1 · Reply

_Crim_Jamer_ May. 20 at 12:26 AM

$PFE tiny gains toady! Let's go!

1 · Reply

Mike22332233 May. 19 at 11:56 PM

1 · Reply

55X_ROI_Q1_2026 May. 19 at 11:37 PM

1 · Reply

Ro_Patel May. 19 at 10:53 PM

1 · Reply

simonds May. 19 at 9:59 PM

$PFE Buckle up, we soar from here!

2 · Reply

integritybuyer May. 19 at 9:18 PM

$IOVA Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ) The Best Penny Stock to Buy Before It Explodes.☄️ Iovance has the first #FDA-approved drug for cellular therapy for a solid tumor #cancer called Amtagvi. Target price on Iovance is $14. Current price $3.46 $IBRX $BFLY $PFE $STEK https://finance.yahoo.com/news/iovance-iova-best-penny-stock-062028121.html

2 · Reply

Mrdrifter May. 19 at 9:02 PM

$PFE https://www.biotechtv.com/post/rbc-global-healthcare-conference-trung-huynh

0 · Reply

55X_ROI_Q1_2026 May. 19 at 8:49 PM

$SLS $LLY $PFE Must really Suck A** being short here now, knowing the 80th EVENT IS COMING and WILL LAUNCH THE SHARE PRICE. - it is a Stone Cold Fact - SLS Share Price will be Launching once we get the 80th Event PR - "VERY SOON" - $18/$20 Per Share in Play on the News and Climbing. - could literally be any day ... and will for sure be happening Very Soon - it Is Inevitable.

1 · Reply

satish474 May. 19 at 7:55 PM

$PFE 27.5 by friday ?)))

2 · Reply

Skyhigh_69 May. 19 at 7:18 PM

$PFE Are we convinced yed that this shit wants to reverse from the downtrend?

2 · Reply

pasuny May. 19 at 7:07 PM

$PFE This garbage is cursed! No worries! I'm taking care of this garbage, Everybody just stay away from this! The power of Christ compels you! The power of Christ compels you!

0 · Reply

traderheadnyc May. 19 at 6:55 PM

$PFE we are on cusp of another breakout of some viral shock all these names will pop up - Though the higher the rates go - this is going to remain lower

0 · Reply

simonds May. 19 at 6:34 PM

$PFE Back to $24.50

0 · Reply

TOOL88 May. 19 at 5:41 PM

$PFE Is there a connection between declines in technology stocks and increases in this stock And vice versa? The trading behavior of this stock is simply strange!

1 · Reply

Micheal_Pothead May. 19 at 5:23 PM

$PFE same thing every time lol

1 · Reply

PFElinepfrenzy1990 May. 19 at 5:00 PM

$PFE and its Deflatey

0 · Reply

simonds May. 19 at 4:52 PM